Axsome Therapeutics' Debt - III Round

Axsome Therapeutics raised a round of funding on September 23, 2014.

Axsome Therapeutics is a clinical stage biopharmaceutical company developing novel therapies for the management of pain and other central nervous system, or CNS, disorders. By focusing on this therape…

Articles about Axsome Therapeutics' Debt - III Round: